Jeevan Scientific Technology Reports Positive Financial Performance in Q2 2024 Despite 'Sell' Recommendation
Jeevan Scientific Technology, a microcap pharmaceutical and drug company, has reported positive financial performance in the second quarter of fiscal year 2024-2025, with a 41.44% increase in net sales and higher profit after tax. However, the company's stock has received a 'Sell' call and its dividend payout ratio is at its lowest in five years. Investors should carefully evaluate all factors before investing.
Jeevan Scientific Technology, a microcap pharmaceutical and drug company, has recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.
Despite the negative recommendation, Jeevan Scientific Technology has shown positive financial performance in the second quarter of the fiscal year 2024-2025. The company's score has fallen from 15 to 8 in the last three months, indicating a decline in overall performance.
However, there are some positive aspects to the company's financials. The net sales for the quarter have grown by 41.44% year on year, reaching Rs 11.40 crore. This shows a strong sales trend in the near term. Additionally, the company's profit after tax for the half-yearly period is higher at Rs 1.33 crore compared to the previous 12 months.
On the other hand, Jeevan Scientific Technology's dividend payout ratio for the year is at its lowest in the last five years, standing at 0.00%. This means that the company is distributing a lower proportion of its profits as dividends.
Overall, Jeevan Scientific Technology has shown mixed financial results for the quarter ending September 2024. Investors should carefully consider all aspects before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
